Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer, Biomarkers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04661826
What this trial is testing

ONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder.

Who this might be right for
Non-Invasive Papillary Carcinoma of Bladder
Fidia Farmaceutici s.p.a. 60
Testing effectiveness (Phase 2)Study completedNCT00963404
What this trial is testing

Image-Guided Tumorboost of Bladder Cancer

Who this might be right for
Bladder Neoplasms
University of Aarhus 19
Not applicableUnknownNCT05467267
What this trial is testing

Personalized Urine Biomarker for Patients With Bladder Cancer

Who this might be right for
Bladder Neoplasm
Ziv Hospital 20
Very early researchStudy completedNCT03039413
What this trial is testing

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Who this might be right for
Bladder Urothelial CarcinomaUrothelial Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Not applicableActive Not RecruitingNCT06129084
What this trial is testing

Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

Who this might be right for
Metastatic Bladder CancerMetastatic Urothelial Carcinoma
Bernie Eigl 260
Not applicableEnded earlyNCT00767234
What this trial is testing

Permission to Collect Blood Over Time for Research

Who this might be right for
Pancreatic CancerGastrointestinal NeoplasmsColon Rectal Cancer Adenocarcinoma+11 more
Stanford University 104
Not applicableStudy completedNCT06281691
What this trial is testing

GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit

Who this might be right for
Urinary Bladder Neoplasms
Jørgen Bjerggaard Jensen 127
Not applicableUnknownNCT05697224
What this trial is testing

Aschistosoma Haematobiumspecific microRNAas a Tumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt

Who this might be right for
Bladder Cancer
Sohag University 50
Not applicableStudy completedNCT04872036
What this trial is testing

Prognostic Biomarkers in Patients With Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Hellenic Cooperative Oncology Group 66
Not applicableUnknownNCT02074241
What this trial is testing

Molecular Markers of Chemosensitivity for Bladder Cancer

Who this might be right for
Bladder CancerEffects of Chemotherapy
Southwest Hospital, China 200
Not applicableLooking for participantsNCT06287541
What this trial is testing

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Not applicableUnknownNCT05864599
What this trial is testing

External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group

Who this might be right for
Non-muscle-invasive Bladder Cancer
Pharmalink 600
Not applicableStudy completedNCT04317261
What this trial is testing

Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria

Who this might be right for
HematuriaBladder Cancer
Mansoura University 181
Not applicableNot Yet RecruitingNCT07454486
What this trial is testing

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Gall Bladder Cancer+11 more
Aarhus University Hospital 300
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Not applicableUnknownNCT04770974
What this trial is testing

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

Who this might be right for
Urothelial CarcinomaBladder CancerUrothelial Neoplasm+2 more
University of Florence 200
Not applicableUnknownNCT03973307
What this trial is testing

UroX Biomarker Bladder Cancer Study

Who this might be right for
Bladder Cancer
East and North Hertfordshire NHS Trust 100
Not applicableStudy completedNCT05362539
What this trial is testing

Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria

Who this might be right for
Bladder Cancer
Mansoura University 246
Not applicableUnknownNCT05220189
What this trial is testing

PENK Methylation Test for Detecting Bladder Cancer

Who this might be right for
Bladder CancerHematuria; Benign
Asan Medical Center 1,549
Testing effectiveness (Phase 2)Active Not RecruitingNCT04953104
What this trial is testing

ARID1A and/or KDM6A Mutation and CXCL13 Expression

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+29 more
M.D. Anderson Cancer Center 6
Next Page